Metabolic syndrome, nephropathy, obesity, retinopathy, and neuropathy are under the role of Nrf2; hence, Nrf2 activation prevents the progression of diabetes and its complications [125]. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.